Do Patients Benefit from Cancer Trial Participation?May 8, 2024MelanomaLung CancerBreast CancerGenitourinary CancerHead & Neck/Thyroid CancersLymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, Transplantation
The Long, Controversial Search for a ‘Cancer Microbiome’May 6, 2024Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersLung CancerMelanoma
Few Cancer Survivors Meet ACS Nutrition, Exercise GuidelinesApril 26, 2024Genitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanomaAML
Most Targeted Cancer Drugs Lack Substantial Clinical BenefitApril 17, 2024Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
No Routine Cancer Screening Option? New MCED Tests May HelpApril 15, 2024MelanomaLymphoma & Plasma Cell DisordersLung CancerLeukemia, Myelodysplasia, TransplantationHead & Neck/Thyroid CancersGenitourinary CancerBreast Cancer
Less Than 50% of Accelerated Approvals Show Clinical BenefitApril 9, 2024Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMelanomaMixed Topics
Virtual Reality Brings Relief to Hospitalized Patients With CancerApril 8, 2024OncologyBreast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell Disorders
Should Opioids Be Used for Chronic Cancer Pain?April 5, 2024Breast CancerFast Facts FridayHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
A Banned Chemical That Is Still Causing CancerApril 3, 2024Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Active Surveillance for Cancer Doesn’t Increase Malpractice RiskApril 1, 2024Genitourinary CancerBreast CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Extraordinary Patients Inspired Father of Cancer ImmunotherapyMarch 19, 2024Mixed TopicsMelanomaLymphoma & Plasma Cell DisordersLung CancerLeukemia, Myelodysplasia, TransplantationHead & Neck/Thyroid CancersGenitourinary Cancer
Unleashing Our Immune Response to Quash CancerFebruary 21, 2024Mixed TopicsAMLMultiple MyelomaBreast CancerMelanomaLung CancerLymphoma & Plasma Cell Disorders
FDA panel voices concerns over 2 lymphoma accelerated approvalsNovember 17, 2023Mixed TopicsAMLMultiple Myeloma
